Back to Journals » International Journal of Nephrology and Renovascular Disease » Volume 14

Prevalence of Anemia and Its Associated Factors Among Chronic Kidney Disease Patients Attending Selected Public Hospitals of Addis Ababa, Ethiopia: Institutional-Based Cross-Sectional Study

Authors Alemu B, Techane T, Dinegde NG, Tsige Y

Received 18 December 2020

Accepted for publication 20 February 2021

Published 5 March 2021 Volume 2021:14 Pages 67—75

DOI https://doi.org/10.2147/IJNRD.S296995

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Pravin Singhal


Birhie Alemu,1 Tesfaye Techane,1 Negalign Getahun Dinegde,2 Yosief Tsige2

1Saint Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia; 2School of Nursing and Midwifery, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia

Correspondence: Tesfaye Techane Email [email protected]

Background: Anemia is a global public health problem with high mortality and morbidity. It is becoming more prevalent in Ethiopia. Therefore, this study aimed to estimate the prevalence of anemia and its associated factors among chronic kidney disease patients at selected public hospitals of Addis Ababa, Ethiopia.
Methods: An institutional-based cross-sectional study was conducted on selected public hospitals in Addis Ababa for studies on anemia in CKD patients. Data was entered into EPI Info version 4.4.1 and exported to SPSS version 24 for analysis. Both bivariate and multivariate logistic regression analyses were used to identify independently associated factors of anemia in CKD patients. Multivariate analysis was used to control the possible effect of confounders.
Results: A total of 387 participants were included to estimate the prevalence of anemia among chronic kidney disease patients. The prevalence of anemia was 53.5% (95% CI). Being females were 2 times more likely to develop anemia as compared to their counterparts (AOR=2.04, 95%:1.18, 2.46) and hemodialysis history had two times higher odds for anemia (AOR=2.754, 95% CI: 1.218– 6.229, P=0.015) compared to patients without hemodialysis history.
Conclusion: The overall prevalence of anemia across all stages of CKD is 53.5%. From the stage of CKD, stage 5 CKD has a higher (90.9%) anemia prevalence compared to others, and females showed a higher frequency of anemia when compared with males. Therefore, situation-based interventions and country context-specific preventive strategies should be developed to reduce the prevalence of anemia in this patient group.

Keywords: chronic kidney disease, anemia, prevalence, Ethiopia

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]